Table 5.
Treatment group | Baseline | 3-month follow-up | 6-month follow-up | |||
---|---|---|---|---|---|---|
Mean (SD) | N | Mean (SD) | N | Mean (SD) | N | |
Female condom attitudes and method specific efficacy (range 1–4) | ||||||
HIV | 2.798 (.341) | 39 | 2.930 (.327) | 35 | 2.868 (.344) | 35 |
Control | 2.801 (.353) | 40 | 2.778 (.417) | 32 | 2.774 (.377) | 34 |
Male condom attitudes and method specific efficacy (range 1–4) | ||||||
HIV | 3.025 (.392) | 39 | 2.988 (.348) | 35 | 2.965 (.297) | 35 |
Control | 2.936 (.342) | 40 | 2.972 (.377) | 32 | 2.912 (.361) | 34 |
Higher means indicate more positive attitudes and perceived efficacy